Adar1 Capital Management, LLC Nurix Therapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $539 Billion
- Q1 2025
A detailed history of Adar1 Capital Management, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 21,200 shares of NRIX stock, worth $200,552. This represents 0.05% of its overall portfolio holdings.
Number of Shares
21,200
Previous 11,000
92.73%
Holding current value
$200,552
Previous $207 Million
21.53%
% of portfolio
0.05%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding NRIX
# of Institutions
182Shares Held
73.2MCall Options Held
56.9KPut Options Held
7.9K-
Black Rock Inc. New York, NY6.82MShares$64.5 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.5MShares$52 Million2.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$41.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.05MShares$38.3 Million5.06% of portfolio
-
Commodore Capital LP New York, NY3.98MShares$37.6 Million4.63% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $446M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...